Want to see KCDMY full AI Analyst Report?
Top Page
Kimberly-Clark de Mexico SAB de CV
(OTC:KCDMY)
Select Model
Select Model
Rating:67Neutral
Price Target:
$11.50
â–²(10.15% Upside)
Action:Reiterated
Date:04/28/26
The score is primarily driven by solid profitability/cash conversion but meaningfully constrained by balance-sheet risk and declining free-cash-flow trend in the provided financial statements. The latest earnings call adds support via improving operations, cost savings, and constructive guidance, while technicals are neutral and valuation is moderately attractive due to the dividend yield and mid-teens P/E.
Positive Factors
Margin Strength
Sustained gross margins near 39% and net margins around 13.7% indicate durable pricing power and operational discipline in core tissue and personal-care categories. High margins support reinvestment, dividend capacity and resilience through cyclical input-cost swings.
Negative Factors
High Leverage / Thin Equity
A high absolute debt load (~MXN 31B) versus a very thin equity base (~MXN 2.5B) leaves limited capitalization cushion. Debt-to-equity near ~3.0x increases sensitivity to earnings volatility or refinancing stress and raises financial risk if margins or cash flow deteriorate.
Read all positive and negative factors
Positive Factors
Negative Factors
Margin Strength
Sustained gross margins near 39% and net margins around 13.7% indicate durable pricing power and operational discipline in core tissue and personal-care categories. High margins support reinvestment, dividend capacity and resilience through cyclical input-cost swings.
Read all positive factors
Kimberly-Clark de Mexico SAB de CV (KCDMY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$6.47B
Dividend Yield4.7%
Average Volume (3M)6.96K
Price to Earnings (P/E)14.9
Beta (1Y)0.21
Revenue Growth5.24%
EPS Growth7.03%
CountryUS
Employees9,513
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)12.85
Shares Outstanding312,725,340
10 Day Avg. Volume0
30 Day Avg. Volume6,964
Financial Highlights & Ratios
PEG Ratio-2.43
Price to Book (P/B)15.97
Price to Sales (P/S)2.23
P/FCF Ratio19.02
Enterprise Value/Market Cap19.30
Enterprise Value/Revenue2.24
Enterprise Value/Gross Profit5.66
Enterprise Value/Ebitda8.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.77
Revenue Forecast (FY)$3.33B
Kimberly-Clark de Mexico SAB de CV Business Overview & Revenue Model
Company Description
Kimberly-Clark de México, S. A. B. de C. V., through its subsidiaries, manufactures and distributes a wide array of disposable consumer goods for everyday use across Mexico. The company's diverse product offering spans several categories: infant c...
How the Company Makes Money
Kimberly-Clark de México makes money primarily by selling branded and/or packaged hygiene and tissue products to retailers, wholesalers, and other distributors that then sell to end consumers. Its core revenue streams are tied to recurring, high-f...
Kimberly-Clark de Mexico SAB de CV Earnings Call Summary
Earnings Call Date:Apr 21, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Jul 21, 2026
Earnings Call Sentiment Positive
The call presented a generally positive performance with record revenue, double-digit increases in gross profit, operating profit, EBITDA and net income, meaningful cost-savings (MXN 450 million) and strong liquidity metrics. Management acknowledged near-term risks including SG&A growth, higher financing cost, FX and commodity volatility (notably an oil-driven raw material cost shock) and a challenging promotional environment that could affect price realization. Operationally, Consumer Products outperformance, sequential recoveries in Away-from-Home and Exports, progress on the KCM+ strategy, and a strengthened debt maturity profile underpin confidence in continued improvement through the year despite transitory cost headwinds.Positive Updates
Record Quarterly Revenue
Sales reached MXN 14.3 billion, a 3.6% increase versus Q1 2025 and an all-time high for the company.
Negative Updates
Away-from-Home Headwinds
Away-from-Home sales decreased 1.3% YoY despite sequential improvement; management expects the business to remain flattish in Q2 and recover in H2.
Read all updates
Q1-2026 Updates
Positive
Negative
Record Quarterly Revenue
Sales reached MXN 14.3 billion, a 3.6% increase versus Q1 2025 and an all-time high for the company.
Read all positive updates
Company Guidance
Management guided that growth should improve through 2026—supported by job creation, higher wages and World Cup spending—with Consumer Products expected to continue leading, Professional (Away‑from‑Home) stabilizing in Q2 and growing in H2, and parent‑roll sales remaining a drag but becoming less so; they noted raw‑material fundamentals support lower dollar prices versus last year but warned of some months of higher costs from the recent oil shock, and to mitigate this have implemented price increases averaging ~4%, will continue revenue‑growth management and cost‑reduction efforts that delivered ~MXN 450 million in Q1. They reiterated margin targets (Q1 EBITDA MXN 3.8 billion, +10.1%, EBITDA margin 26.7% at the upper end of the long‑term range; gross profit +11.1%, operating profit +11.9%, operating margin 23.2%, net income MXN 2.0 billion, +10.2%, EPS MXN 0.68, +13.3%) and emphasized FX tailwinds (~15% lower FX vs prior year), a strong balance sheet (cash MXN 20.4 billion, net debt/EBITDA 0.9x, EBITDA/net interest ~9x) and a MXN 10 billion debt placement to improve maturities and preserve optionality for potential M&A.Kimberly-Clark de Mexico SAB de CV Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
46
Neutral
Cash Flow
63
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.74B | 51.94B | 54.78B | 53.31B | 51.06B | 46.89B |
| Gross Profit | 22.07B | 20.19B | 22.38B | 20.70B | 16.77B | 15.79B |
| EBITDA | 14.92B | 13.85B | 16.09B | 15.23B | 11.58B | 10.79B |
| Net Income | 7.75B | 7.11B | 7.83B | 7.01B | 4.94B | 4.49B |
Balance Sheet | ||||||
| Total Assets | 56.84B | 45.71B | 52.11B | 53.92B | 53.54B | 48.78B |
| Cash, Cash Equivalents and Short-Term Investments | 20.18B | 9.68B | 15.58B | 16.86B | 16.92B | 12.27B |
| Total Debt | 31.03B | 21.36B | 28.10B | 29.72B | 34.15B | 29.83B |
| Total Liabilities | 54.34B | 38.46B | 44.70B | 47.00B | 48.51B | 43.06B |
| Stockholders Equity | 2.50B | 7.25B | 7.41B | 6.92B | 5.03B | 5.72B |
Cash Flow | ||||||
| Free Cash Flow | 7.03B | 6.09B | 8.10B | 11.08B | 6.18B | 4.65B |
| Operating Cash Flow | 8.76B | 7.80B | 10.60B | 12.76B | 8.32B | 6.80B |
| Investing Cash Flow | -1.59B | -1.72B | -1.30B | -311.39M | -2.15B | -2.14B |
| Financing Cash Flow | 2.08B | -11.02B | -13.50B | -9.83B | -1.32B | -11.07B |
Kimberly-Clark de Mexico SAB de CV Technical Analysis
Positive
10.44
Price Trends
11.14
Negative
11.49
Negative
10.80
Positive
Market Momentum
-0.03
Negative
53.14
Neutral
93.89
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KCDMY, the sentiment is Positive. The current price of 10.44 is below the 20-day moving average (MA) of 10.80, below the 50-day MA of 11.14, and below the 200-day MA of 10.80, indicating a neutral trend. The MACD of -0.03 indicates Negative momentum. The RSI at 53.14 is Neutral, neither overbought nor oversold. The STOCH value of 93.89 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for KCDMY.
Kimberly-Clark de Mexico SAB de CV Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $129.12B | 27.81 | 26.01% | 3.74% | -13.78% | 11.80% | |
67 Neutral | $6.47B | 14.91 | 161.39% | 4.70% | 5.24% | 7.03% | |
65 Neutral | $22.96B | 31.95 | 17.45% | 1.38% | 2.22% | 29.40% | |
64 Neutral | $73.36B | 35.35 | 475.13% | 2.67% | 4.26% | -27.12% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | $36.44B | 17.29 | 143.64% | 5.03% | -16.17% | -13.40% | |
58 Neutral | $11.54B | 15.24 | 2826.17% | 5.05% | -3.69% | 10.26% |
* Consumer Defensive Sector Average
KCDMY
Kimberly-Clark de Mexico SAB de CV
11.05
2.18
24.62%
CHD
Church & Dwight
96.88
0.12
0.12%
CLX
Clorox
95.44
-23.84
-19.99%
CL
Colgate-Palmolive
91.68
1.56
1.73%
KMB
Kimberly Clark
109.77
-16.41
-13.01%
UL
Unilever
60.12
-3.45
-5.42%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.